SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Trading Update

25 Mar 2020 07:00

RNS Number : 4692H
Rentokil Initial PLC
25 March 2020
 

  

RENTOKIL INITIAL PLC (RTO)

 

Rentokil Initial plc provides a COVID-19 (Coronavirus) trading update

 

Introduction

 

At the time of our Preliminary results in February we gave a brief update on the impact of the Coronavirus outbreak on our operations. We said that the main impact at the end of February was on our operations in China, which saw business closures and employees unable to service their customers, and that in other parts of the Group customer enquiries for hand hygiene services were strong and hence we were anticipating an overall strong performance in Q1. Our view was that we would expect only a small net impact on the business in the quarter from the Coronavirus but should the situation become materially worse, this would have a more negative impact during the rest of the year.

 

In the last 10 days the outbreak has escalated rapidly impacting businesses around the globe in an unprecedented manner. The situation remains highly uncertain and it is therefore impossible to predict with any degree of certainty the impact this will have, however, we do now expect a much more significant impact on our operations and performance in Q2 and beyond. In this period of unprecedented uncertainty we are consequently withdrawing our previous guidance for 2020. We will update the market on our Q1 trading performance and further on the potential impact of the Coronavirus on 16 April 2020.

 

Protecting people, customers and colleagues

 

The safety of our people is of paramount importance and we have implemented a series of actions to protect the health and safety of our colleagues and customers. These include restricting travel and meetings, the adoption of flexible working arrangements and the recommendation to colleagues and customers to follow specific health protection protocols. We are utilising technology to allow for greater home working such as video conferencing.

Our mission at Rentokil Initial is to Protect People and Enhance Lives. We have pest control operations in over 80 countries and hygiene services in 46. The situation is particularly complex due in part to the wide range in COVID-19 infection rates as well as differences in government action across the world. Many of the global markets in which we operate have designated Pest Control and Hygiene as critical and essential services, with other markets likely to follow in coming weeks, enabling us to play our part in fighting the spread of COVID-19. We also have an essential role to play in minimising pest risks to our customers in these challenging times.

 

Impact on operations, categories and market sectors

 

Group trading to mid-March was not materially impacted by the virus outbreak. China trading was largely suspended in early February with a gradual return to service for 56% of customers at the end of that month and is now servicing around 75% of customers. At mid-March the main country impacted within the Group was Italy where business closures and a national lockdown had reduced service levels by around 40%.

 

Within the last ten days, however, the impact on our global businesses has significantly increased. COVID-19 has affected the majority of the key countries in our Group with many markets in advanced stages of lockdown. The impact of the virus on our businesses to date has been varied, dependent on factors including the rate at which the virus has spread, individual government response and required levels of customer service.

 

Some customer sectors have been substantially closed due to government and voluntary actions taken to limit the impact of the virus. This includes the HORECA sector (Hotels, Restaurants and Catering), the airline industry, schools and some offices. Conversely demand for our services in areas such as food production, food retailing and healthcare have been strong with increased demand for specialist hygiene services, particularly hygiene disinfection services, across a number of our markets.

Balance sheet, liquidity and headroom

While significant uncertainty exists around the impact of COVID-19, we have taken immediate action to reduce costs and optimise cash flow and liquidity. We have suspended our M&A programme and have also decided to suspend dividend payments for the time being, withdrawing therefore the final dividend proposed at the Preliminary results in February, and have drawn down on our Revolving Credit Facility (RCF) meaning that the Group now has cash funds available of over £650m. This excludes any funding under the Government's Commercial Paper (CP) scheme announced on 17 March. Our RCF has a Net Debt to EBITDA covenant of 3.5x net debt to EBITDA which can be increased to 4.0x in certain circumstances. As at 31 December 2019 our net debt to EBITDA ratio was 1.8x.

Cost reduction measures

In the immediate term, the majority of Group costs are fixed with the main variable cost being materials supplied and fuel costs incurred in servicing our customers (typically around 15% of revenues). The main cost in our business is employment costs which are c.45% of Group revenues. To mitigate the impact of revenue shortfalls, we have taken a number of cost saving measures to protect the profitability and cash generation of the business:

· Pay cuts have been made across the Board and all senior management grades, with bonus schemes cancelled and the 2020 LTIP grant postponed. Reductions in other employment costs are being evaluated;

· A freeze in hiring and significant restrictions on the use of overtime and contractors have been implemented;

· Marketing budgets have been significantly scaled back and refocused;

· Travel and entertainment, meetings and external training have been stopped; and

· Government support is being applied for where appropriate to support the costs of employees.

The above measures will reduce our costs in 2020 by c.£100m.

 

Cash conservation measures

 

We have also taken the following measures to ensure that the Group is able to make appropriate investments in products and services where demand is high, while conserving cash as far as possible where services have been disrupted:

· All discretionary capex has been suspended - we now expect capex to reduce by at least £75m in 2020 to below £200m;

· Receivables will be managed with extra vigilance in respect of credit risk;

· Inventory management has increased with a focus on high-demand products; and

· Cash tax spend for 2020 will be actively managed, with an expectation that payments can be reduced to below £35m a reduction of least £25m compared to previous guidance. We are also reviewing opportunities to defer other tax amounts such as VAT, PAYE and Social Security.

As noted above we have also suspended our M&A programme and suspended dividend payments conserving around £300m of cash for the year compared to previous guidance. This combined with the other cash and cost saving actions noted above will conserve over £500m of cash in the year.

 

Global leaders in Pest Control and Hygiene

As the pandemic develops we are responding to the increased global demand for hygiene services including general and specialist disinfection services (requiring specialist personal protective equipment and Coronavirus-specific training) and precautionary disinfection risk assessment surveys. We anticipate demand will increase throughout the pandemic and during the recovery phase. We are training our staff to help support this increased demand and by the end of March we expect to have at least an additional 2,500 technicians trained around the world to undertake disinfection services.

When the crisis ends we envisage that there will be a significant demand for hygiene and pest control clean up services. We also consider it likely that global standards in hygiene will increase significantly on an ongoing basis. The measures we have taken to protect our colleagues and our financial resources, and help our customers throughout this period, will best position us to come out of the pandemic ready to meet the needs of the global pest control and hygiene markets.

Commenting on today's announcement Andy Ransom, Chief Executive, said:

"Rentokil Initial is a strong and resilient company offering critical and essential Pest Control and Hygiene services to customers. While we had made a good start to the year, the ongoing uncertainty and turmoil presented by the COVID-19 outbreak will mean we will have a difficult second quarter and potentially beyond. However, we are taking appropriate cost and cash action to protect the business and our liquidity, and to put us in the best position to support the recovery phase.

 

"I would like to thank my colleagues for the bravery and commitment they have shown as this crisis has unfolded and we will do everything we can to continue to protect our colleagues, customers and shareholders in these unprecedented times."

 

Enquiries:

 

Investors / Analysts:

Katharine Rycroft

Rentokil Initial plc

07811 270734

Media:

Malcolm Padley

Rentokil Initial plc

07788 978199

This announcement contains statements that are, or may be, forward-looking regarding the Group's financial position and results, business strategy, plans and objectives. Such statements involve risk and uncertainty because they relate to future events and circumstances and there are accordingly a number of factors which might cause actual results and performance to differ materially from those expressed or implied by such statements. Forward-looking statements speak only as of the date they are made and no representation or warranty, whether expressed or implied, is given in relation to them, including as to their completeness or accuracy or the basis on which they were prepared. Other than in accordance with the Company's legal or regulatory obligations (including under the Listing Rules and the Disclosure Guidance and Transparency Rules), the Company does not undertake any obligation to update or revise publicly any forward-looking statement, whether as a result of new information, future events or otherwise. Information contained in this announcement relating to the Company or its share price, or the yield on its shares, should not be relied upon as an indicator of future performance. Nothing in this announcement should be construed as a profit forecast.

 

The Company will be announcing its scheduled Trading Update for Q1 on 16 April 2020.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFFFFLVDISFII
Date   Source Headline
28th Jul 20253:00 pmRNSHolding(s) in Company
10th Jul 202511:00 amRNSHolding(s) in Company
1st Jul 202510:25 amRNSTotal Voting Rights
10th Jun 202510:05 amRNSAdditional Listing
3rd Jun 20254:00 pmRNSDirector/PDMR Shareholding
28th May 20257:00 amRNSSale of France Workwear
19th May 20252:30 pmRNSDirector/PDMR Shareholding
7th May 20254:15 pmRNSResult of AGM
7th May 20257:01 amRNSDirectorate Change: Appointment of NEDs
7th May 20257:00 amRNSDirectorate Change: Chief Executive to retire
28th Apr 20252:30 pmRNSIssue of Debt
17th Apr 20252:20 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 Trading Update
9th Apr 202510:25 amRNSHolding(s) in Company
1st Apr 20252:15 pmRNSNotice of Q1 Trading Update and Management Call
1st Apr 202510:25 amRNSBlock listing Interim Review
27th Mar 202510:25 amRNSDirector/PDMR Shareholding
26th Mar 202510:30 amRNSAnnual Financial Report
14th Mar 202510:00 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results
28th Jan 20257:00 amRNSTrading Update (unaudited)
14th Jan 202511:15 amRNSHolding(s) in Company
13th Jan 202511:15 amRNSHolding(s) in Company
13th Dec 20249:30 amRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNSDirectorate Change
12th Nov 202410:30 amRNSHolding(s) in Company
8th Nov 202410:30 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSQ3 Trading Update
1st Oct 20242:00 pmRNSBlock listing Interim Review
25th Sep 20247:00 amRNSAppointment of Non-Executive Director
19th Sep 202410:30 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSTrading Update
10th Sep 202410:30 amRNSHolding(s) in Company
5th Sep 202411:08 amRNSHolding(s) in Company
25th Jul 20247:00 amRNS2024 Interim Results
10th Jul 20244:35 pmRNSHolding(s) in Company
26th Jun 20245:12 pmRNSDirector/PDMR Shareholding
26th Jun 202411:08 amRNSHolding(s) in Company
17th May 20243:30 pmRNSDirector/PDMR Shareholding
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.